Genetic engineering meets hematopoietic stem cell biology for next-generation gene therapy
The growing clinical success of hematopoietic stem/progenitor cell (HSPC) gene therapy
(GT) relies on the development of viral vectors as portable" Trojan horses" for safe and …
(GT) relies on the development of viral vectors as portable" Trojan horses" for safe and …
Genetic engineering meets hematopoietic stem cell biology for next-generation gene therapy
S Ferrari, E Valeri, A Conti, S Scala, A Aprile… - Cell stem …, 2023 - pubmed.ncbi.nlm.nih.gov
The growing clinical success of hematopoietic stem/progenitor cell (HSPC) gene therapy
(GT) relies on the development of viral vectors as portable" Trojan horses" for safe and …
(GT) relies on the development of viral vectors as portable" Trojan horses" for safe and …
Genetic engineering meets hematopoietic stem cell biology for next-generation gene therapy.
S Ferrari, E Valeri, A Conti, S Scala, A Aprile… - Cell Stem …, 2023 - europepmc.org
The growing clinical success of hematopoietic stem/progenitor cell (HSPC) gene therapy
(GT) relies on the development of viral vectors as portable" Trojan horses" for safe and …
(GT) relies on the development of viral vectors as portable" Trojan horses" for safe and …
[HTML][HTML] Genetic engineering meets hematopoietic stem cell biology for next-generation gene therapy
S Ferrari, E Valeri, A Conti, S Scala, A Aprile… - Cell Stem Cell, 2023 - Elsevier
The growing clinical success of hematopoietic stem/progenitor cell (HSPC) gene therapy
(GT) relies on the development of viral vectors as portable “Trojan horses” for safe and …
(GT) relies on the development of viral vectors as portable “Trojan horses” for safe and …